A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 05 Sep 2018
At a glance
- Drugs Insulin lispro/pramlintide (Primary) ; Insulin lispro; Pramlintide
- Indications Type 1 diabetes mellitus
- Focus First in man; Pharmacokinetics
- Sponsors Adocia
- 05 Sep 2018 According to an Adocia media release, these results will be published separately.
- 05 Sep 2018 Top-line results are presented in an Adocia media release.
- 18 Jul 2018 According to an Adocia media release, top-line results from the trial are expected in Q3 2018.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History